3. Not cutting back on innovation
Baxter CEO Joe Almeida spoke of a 100% focus on innovation at the company. “We have no intention to let that down one iota. … We are responsible people here who will do the right thing to make sure that our expenses are in control. Everybody knows that. But there is a bigger commitment to innovation and to our research and development groups, which are doing an extraordinary job under very difficult circumstances to have data-completing clinical trials, data submitted to agencies for product approval.”